Skip to Main content Skip to Navigation
Journal articles

Inhibition of effector antigen-specific T cells by intradermal administration of heme oxygenase-1 inducers

Abstract : Developing protocols aimed at inhibiting effector T cells would be key for the treatment of T cell-dependent autoimmune diseases including type 1 autoimmune diabetes (T1D) and multiple sclerosis (MS). While heme oxygenase-1 (HO-1) inducers are clinically approved drugs for non-immune-related diseases, they do have immunosuppressive properties when administered systemically in rodents. Here we show that HO-1 inducers inhibit antigen-specific effector T cells when injected intradermally together with the T cell cognate antigens in mice. This phenomenon was observed in both a CD8 þ T cell-mediated model of T1D and in a CD4 þ T cell-dependent MS model. Intradermal injection of HO-1 in-ducers induced the recruitment of HO-1 þ monocyte-derived dendritic cell (MoDCs) exclusively to the lymph nodes (LN) draining the site of intradermal injection. After encountering HO-1 þ MoDCs, effector T-cells exhibited a lower velocity and a reduced ability to migrate towards chemokine gradients resulting in impaired accumulation to the inflamed organ. Intradermal co-injection of a clinically approved HO-1 inducer and a specific antigen to non-human primates also induced HO-1 þ MoDCs to accumulate in dermal draining LN and to suppress delayed-type hypersensitivity. Therefore, in both mice and non-human primates, HO-1 inducers delivered locally inhibited effector T-cells in an antigen-specific manner, paving the way for repositioning these drugs for the treatment of immune-mediated diseases.
Document type :
Journal articles
Complete list of metadata

Cited literature [32 references]  Display  Hide  Download
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Monday, May 15, 2017 - 11:31:12 AM
Last modification on : Friday, August 5, 2022 - 3:02:42 PM
Long-term archiving on: : Thursday, August 17, 2017 - 12:38:52 AM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document


Distributed under a Creative Commons Attribution - ShareAlike 4.0 International License



Thomas Simon, Julien Pogu, Séverine Rémy, Frédéric Brau, Sylvie Pogu, et al.. Inhibition of effector antigen-specific T cells by intradermal administration of heme oxygenase-1 inducers. Journal of Autoimmunity, Elsevier, 2017, 81, pp.44-55. ⟨10.1016/j.jaut.2017.03.005⟩. ⟨inserm-01522579⟩



Record views